SUDAFED PE EXTRA STRENGTH 10 MG
PHENYLEPHRINE HYDROCHLORIDE : 10 MG · DIN 02250217 · MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
Health Canada status: CANCELLED POST MARKET
What is SUDAFED PE EXTRA STRENGTH?
SUDAFED PE EXTRA STRENGTH 10 MG contains PHENYLEPHRINE HYDROCHLORIDE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02250217, held by MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Dec-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02250217 |
|---|---|
| Brand name | SUDAFED PE EXTRA STRENGTH |
| Generic / active ingredient | PHENYLEPHRINE HYDROCHLORIDE : 10 MG |
| Manufacturer | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC |
| Strength | 10 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01BA03 PHENYLEPHRINE |
| AHFS class | 12:12.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Dec-2025 |
| Original market date | 2006-05-10 00:00:00 |
Is PHENYLEPHRINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code R01BA03 PHENYLEPHRINE. 0 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BENYLIN COLD STRIPS | 10 MG | STRIP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED PRE MARKET | DIN 02262304 |
| BENYLIN D FOR INFANTS | 1.25 MG / 0.8 ML | SOLUTION | PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | CANCELLED POST MARKET | DIN 02281341 |
| HELP I HAVE A STUFFY NOSE | 5 MG | TABLET | HELP REMEDIES INC | CANCELLED (UNRETURNED ANNUAL) | DIN 02374161 |
| HELP I HAVE THE SNIFFLES | 5 MG | TABLET | HELP REMEDIES INC | CANCELLED (UNRETURNED ANNUAL) | DIN 02376407 |
| LITTLE NOSES DECONGESTANT NOSE DROPS | 0.125 % | LIQUID | PRESTIGE BRANDS INC | CANCELLED POST MARKET | DIN 02270056 |
| NASAL DECONGESTANT | 10 MG | TABLET | JAMP PHARMA CORPORATION | APPROVED | DIN 02292548 |
| NOVAHISTINE DECON LIQ 5MG/5ML | 5 MG / 5 ML | LIQUID | MERRELL PHARMS INC., DIVISION OF MERRELL DOW (CAN) | CANCELLED POST MARKET | DIN 01936670 |
| NOVAHISTINE DECONGESTANT - LIQ 5MG/5ML | 5 MG / 5 ML | LIQUID | HOECHST MARION ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 02103001 |
| SINUS PE DECONGESTANT | 10 MG | TABLET | CELLCHEM PHARMACEUTICALS INC. | APPROVED | DIN 02322439 |
| SUDAFED PE REGULAR STRENGTH | 5 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED PRE MARKET | DIN 02250209 |
Who else supplies PHENYLEPHRINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PHENYLEPHRINE appears in 51 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.